Eight hospitals in Australia will conduct a 4-year trial of a vaccine for children with malignant brain cancer, involving approximately 70 young patients.
Professor Richard Scolyer, a world-leading cancer expert who self-experimented with immunotherapy, is facing memory and motor skill decline as his brain tumor worsens.
